“Profile of patients with rheumatic diseases undergoing treatment with anti-TNF agents in the Brazilian Public Health System (SUS), Belo Horizonte - MG” (2015) Brazilian Journal of Pharmaceutical Sciences, 51(3), pp. 709–719. doi:10.1590/S1984-82502015000300023.